The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes

Atherosclerosis

Volumn 136, Issue 1, 1998, Pages 109-114

  Iwai, Naoharu ^a   Shimoike, Hitoshi ^a   Nakamura, Yasuyuki ^a   Tamaki, Shinji ^a   Kinoshita, Masahiko ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Angina; Genetics; Myocardial infarction; Plasminogen activators

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; ALLELES; ANGINA PECTORIS; FEMALE; FIBRINOLYSIS; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TIME FACTORS;

EID: 0031853098     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00191-3     Document Type: Article

References (22)

1. Hamsten A., Wiman B., De Daire U., Blombaeck M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med. 313:1985;1557-1563.
2. Hamsten A., De Faire U., Walldius G., Dahlen G., Szamosi A., Landou C., Blombaeck M., Wiman B. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet. 2:1987;3-9.
3. Cortellaro M., Cofrancesco E., Boschetti C., Mussoni L., Donati M.B., Cardillo M., Catalano M., Gabrielli L., Lombardi B., Specchia G., Tavazzi L., Tremoli E., Pozzoli E., Turri M. For the PLAT group. Increased fibrin turnover and high PAI-I activity as predictors of ischemic events in atherosclerotic patients: a case-control study. Arterioscler Thromb. 13:1993;1412-1417.
4. Juhan-Vague I., Pyke S.D.M., Alessi M.C., Jespersen J., Haverkate F., Thompson S.G. On behalf of the ECAT study group. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation. 94:1996;2057-2063.
5. Dawson S.J., Wiman B., Hamsten A., Green F., Humphries S., Henney A.M. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem. 268:1993;10739-10745.
6. Eriksson P., Kallin B., van't Hooft F.M., Bavenholm P., Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA. 92:1995;1851-1855.
7. Ye S., Green F.R., Scarabin P.Y., Nicaud V., Bara L., Dawson S.J., Humphries S.E., Evans A., Luc G., Cambou J.P., Arveiler D., Henney A.M., Cambien F. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 gene is associated with differences in plasma PAI-i activity but not with risk of myocardial infarction in the ECTIM study. Thromb Haemost. 74:1995;837-841.
8. Ridker P.M., Hennekens C.H., Lindpainter K., Stampfer M.J., Miletich J.P. Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men. Circulation. 95:1997;59-62.
9. Fuster V., Badimon L., Badimon J.J., Chesebro J.H. The pathogenesis of coronary artery disease and acute coronary syndromes. N Engl J Med. 326:1992;242-250.
10. Fuster V., Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation. 90:1994;2126-2146.
11. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 91:1995;2844-2850.
12. Braunwald E. Unstable angina. Circulation. 80:1989;410-414.
13. Iwai N., Ohmichi N., Nakamura Y., Kinoshita M. DD genotype of the angiotensin converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation. 90:1994;2622-2628.
14. Mansfield M.W., Stickland M.H., Grant P.J. Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in Caucasian patients with non-insulin-dependent diabetes mellitus. Thromb Haemost. 74:1995;842-847.
15. Cambien F., Poirier O., Lecerf L., Evans A., Cambou J.P., Arveiler D., Luc G., Bard J.M., Bara L., Ricard S., Tiret L., Amouyel P., Alhenc-Gelas F., Soubrier F. Deletion polymorphism in angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 359:1992;641-644.
16. Bloem L.J., Manatunga A.K., Tewksbury D.A., Pratt H.J. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest. 95:1995;948-953.
17. Juhan-Vague I., Thompson S.G., Jesperson J. On behalf of the ECAT angina pectoris study group. Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. Arterioscler Thromb. 13:1993;1865-1873.
18. Nordt T.K., Sawa H., Fujii S., Sobel B.E. Induction of plasminogen activator inhibitor type-1 by proinsulin and insulin in vivo. Circulation. 91:1995;764-770.
19. Caron P., Bennet A., Camare R., Louvet J.P., Boneu B., Sie P. Plasminogen activator inhibitor in plasma is related to testosterone in men. Metabolism. 38:1989;1010-1015.
20. Yang X.C., Jing T.Y., Resnick L.M., Phillips G.B. Relation of hemostatic risk factors to other risk factors for coronary heart disease and to sex hormone in men. Arterioscler Thromb. 13:1993;467-471.
21. Kerins D.M., Hao Q., Vaughan D.E. Angiotensin induction of PAI-1 in endothelial cells is mediated by the hexapeptide angiotensin IV. J Clin Invest. 96:1995;2515-2520.
22. van der Wal A., Becker A.E., van der Loos C.M., Das P.K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 89:1994;36-44.